245 related articles for article (PubMed ID: 23708211)
21. p53 and Pten control neural and glioma stem/progenitor cell renewal and differentiation.
Zheng H; Ying H; Yan H; Kimmelman AC; Hiller DJ; Chen AJ; Perry SR; Tonon G; Chu GC; Ding Z; Stommel JM; Dunn KL; Wiedemeyer R; You MJ; Brennan C; Wang YA; Ligon KL; Wong WH; Chin L; DePinho RA
Nature; 2008 Oct; 455(7216):1129-33. PubMed ID: 18948956
[TBL] [Abstract][Full Text] [Related]
22. A Trp53fl/flPtenfl/fl mouse model of undifferentiated pleomorphic sarcoma mediated by adeno-Cre injection and in vivo bioluminescence imaging.
Buchakjian MR; Merritt NM; Moose DL; Dupuy AJ; Tanas MR; Henry MD
PLoS One; 2017; 12(8):e0183469. PubMed ID: 28841687
[TBL] [Abstract][Full Text] [Related]
23. Genomic Landscape of Uterine Sarcomas Defined Through Prospective Clinical Sequencing.
Hensley ML; Chavan SS; Solit DB; Murali R; Soslow R; Chiang S; Jungbluth AA; Bandlamudi C; Srinivasan P; Tap WD; Rosenbaum E; Taylor BS; Donoghue MTA; Hyman DM
Clin Cancer Res; 2020 Jul; 26(14):3881-3888. PubMed ID: 32299819
[TBL] [Abstract][Full Text] [Related]
24. PTEN/MMAC1 gene mutation is a rare event in soft tissue sarcomas without specific balanced translocations.
Saito T; Oda Y; Kawaguchi K; Takahira T; Yamamoto H; Tamiya S; Tanaka K; Matsuda S; Sakamoto A; Iwamoto Y; Tsuneyoshi M
Int J Cancer; 2003 Mar; 104(2):175-8. PubMed ID: 12569572
[TBL] [Abstract][Full Text] [Related]
25. Expression of subtype-specific group 1 leiomyosarcoma markers in a wide variety of sarcomas by gene expression analysis and immunohistochemistry.
Mills AM; Beck AH; Montgomery KD; Zhu SX; Espinosa I; Lee CH; Subramanian S; Fletcher CD; van de Rijn M; West RB
Am J Surg Pathol; 2011 Apr; 35(4):583-9. PubMed ID: 21412072
[TBL] [Abstract][Full Text] [Related]
26. Chromosome 17 abnormalities and TP53 mutations in adult soft tissue sarcomas.
Latres E; Drobnjak M; Pollack D; Oliva MR; Ramos M; Karpeh M; Woodruff JM; Cordon-Cardo C
Am J Pathol; 1994 Aug; 145(2):345-55. PubMed ID: 8053493
[TBL] [Abstract][Full Text] [Related]
27. Notch-1 signaling is lost in prostate adenocarcinoma and promotes PTEN gene expression.
Whelan JT; Kellogg A; Shewchuk BM; Hewan-Lowe K; Bertrand FE
J Cell Biochem; 2009 Aug; 107(5):992-1001. PubMed ID: 19479935
[TBL] [Abstract][Full Text] [Related]
28. Relationships between highly recurrent tumor suppressor alterations in 489 leiomyosarcomas.
Schaefer IM; Lundberg MZ; Demicco EG; Przybyl J; Matusiak M; Chibon F; Ingram DR; Hornick JL; Wang WL; Bauer S; Baker LH; Lazar AJ; van de Rijn M; Mariño-Enríquez A; Fletcher JA
Cancer; 2021 Aug; 127(15):2666-2673. PubMed ID: 33788262
[TBL] [Abstract][Full Text] [Related]
29. Notch signaling in pediatric soft tissue sarcomas.
Rota R; Ciarapica R; Miele L; Locatelli F
BMC Med; 2012 Nov; 10():141. PubMed ID: 23158439
[TBL] [Abstract][Full Text] [Related]
30. Comprehensive mapping of p53 pathway alterations reveals an apparent role for both SNP309 and MDM2 amplification in sarcomagenesis.
Ito M; Barys L; O'Reilly T; Young S; Gorbatcheva B; Monahan J; Zumstein-Mecker S; Choong PF; Dickinson I; Crowe P; Hemmings C; Desai J; Thomas DM; Lisztwan J
Clin Cancer Res; 2011 Feb; 17(3):416-26. PubMed ID: 21159888
[TBL] [Abstract][Full Text] [Related]
31. p53: functions, mutations and sarcomas.
Hung J; Anderson R
Acta Orthop Scand Suppl; 1997 Feb; 273():68-73. PubMed ID: 9057590
[TBL] [Abstract][Full Text] [Related]
32. MiR-30e-3p Influences Tumor Phenotype through
Gramantieri L; Pollutri D; Gagliardi M; Giovannini C; Quarta S; Ferracin M; Casadei-Gardini A; Callegari E; De Carolis S; Marinelli S; Benevento F; Vasuri F; Ravaioli M; Cescon M; Piscaglia F; Negrini M; Bolondi L; Fornari F
Cancer Res; 2020 Apr; 80(8):1720-1734. PubMed ID: 32015093
[TBL] [Abstract][Full Text] [Related]
33. p53 Maintains Baseline Expression of Multiple Tumor Suppressor Genes.
Pappas K; Xu J; Zairis S; Resnick-Silverman L; Abate F; Steinbach N; Ozturk S; Saal LH; Su T; Cheung P; Schmidt H; Aaronson S; Hibshoosh H; Manfredi J; Rabadan R; Parsons R
Mol Cancer Res; 2017 Aug; 15(8):1051-1062. PubMed ID: 28483946
[No Abstract] [Full Text] [Related]
34. The differentiation stage of p53-Rb-deficient bone marrow mesenchymal stem cells imposes the phenotype of in vivo sarcoma development.
Rubio R; Gutierrez-Aranda I; Sáez-Castillo AI; Labarga A; Rosu-Myles M; Gonzalez-Garcia S; Toribio ML; Menendez P; Rodriguez R
Oncogene; 2013 Oct; 32(41):4970-80. PubMed ID: 23222711
[TBL] [Abstract][Full Text] [Related]
35. Noncanonical roles of p53 in cancer stemness and their implications in sarcomas.
Curylova L; Ramos H; Saraiva L; Skoda J
Cancer Lett; 2022 Jan; 525():131-145. PubMed ID: 34742870
[TBL] [Abstract][Full Text] [Related]
36. Genetic and epigenetic alterations of the PTEN gene in soft tissue sarcomas.
Kawaguchi K; Oda Y; Saito T; Takahira T; Yamamoto H; Tamiya S; Iwamoto Y; Tsuneyoshi M
Hum Pathol; 2005 Apr; 36(4):357-63. PubMed ID: 15891996
[TBL] [Abstract][Full Text] [Related]
37. High-Grade Sarcomas with Myogenic Differentiation Harboring Hotspot PDGFRB Mutations.
Dermawan JK; Chiang S; Hensley ML; Tap WD; Antonescu CR
Mod Pathol; 2023 May; 36(5):100104. PubMed ID: 36788091
[TBL] [Abstract][Full Text] [Related]
38. Mutational analysis of the PTEN gene in human uterine sarcomas.
Lancaster JM; Risinger JI; Carney ME; Barrett JC; Berchuck A
Am J Obstet Gynecol; 2001 May; 184(6):1051-3. PubMed ID: 11349153
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of Notch Signaling Promotes the Adipogenic Differentiation of Mesenchymal Stem Cells Through Autophagy Activation and PTEN-PI3K/AKT/mTOR Pathway.
Song BQ; Chi Y; Li X; Du WJ; Han ZB; Tian JJ; Li JJ; Chen F; Wu HH; Han LX; Lu SH; Zheng YZ; Han ZC
Cell Physiol Biochem; 2015; 36(5):1991-2002. PubMed ID: 26202359
[TBL] [Abstract][Full Text] [Related]
40. Mutational analysis of p53 and PTEN in soft tissue sarcoma.
Yin L; Liu CX; Nong WX; Chen YZ; Qi Y; Li HA; Hu WH; Sun K; Li F
Mol Med Rep; 2012 Feb; 5(2):457-61. PubMed ID: 22052239
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]